archiveNovember 28, 2024

Business

Armistice Capital 13F Reveals Strategic Investment Focus in Neuromuscular Research and Development

The landscape of neuromuscular disease treatment is experiencing significant transformation, driven by pressing medical needs and emerging therapeutic approaches. With more than 30 distinct neuromuscular disorders currently recognized, the limited availability of approved treatments has created a compelling opportunity for research and investment in this specialized field. The current therapeutic...